Close Menu

Advion

NEW YORK (GenomeWeb News) – Advion said on Monday it has signed an exclusive original equipment manufacturing and distribution partnership deal with Swiss firm CAMAG for Advion's TLC/MS interface product.

NEW YORK (GenomeWeb News) – Advion today said that it has inked a distribution agreement with Konik Group covering Spain, Portugal, and South America, excluding Brazil.

NEW YORK (GenomeWeb News) – Advion today said that its expression compact mass spectrometer has been integrated with liquid chromatography systems from Agilent Technologies.

NEW YORK (GenomeWeb News) – Advion today said that it has signed an agreement with Valtex International for distribution of the firm's expression compact mass spectrometer in Russia.

While LC-MS/MS workflows using triple quadrupoles and, more recently, Q-TOF and Q-Exactive instruments, have typically dominated discussion of mass spec-based protein quantitation, MALDI mass spec has recently emerged as a potential alternative for such applications.

NEW YORK (GenomeWeb News) – Advion said late on Thursday it has named Government Scientific Source as a US government distributor for the company's new expression CMS compact mass spec.

Alex Bateman is joining the European Bioinformatics Institute as head of protein sequence resources, replacing Rolf Apweiler.

NEW YORK (GenomeWeb News) – Advion today announced the appointment of Scientifix as the exclusive distributor for its expression compact mass spectrometer in Australia.

NEW YORK (GenomeWeb News) – Life sciences and consumables firm Advion continued on its expansion into the international markets today announcing a deal with Yair Technologies for the distribution of Advion's expression compact mass spectrometer in Israel.

NEW YORK (GenomeWeb News) – Advion today said it has appointed Inkarp Instruments to be its distributor in India.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.